Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01415609 · ClinicalTrials.gov registry record
Endoscopic Submucosal Dissection Registry
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 17
- Enrollment target
NCT01415609: Completed study, sponsored by Mayo Clinic.
NCT01415609 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01415609 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to monitor the success rates and completion rates for endoscopic submucosal dissection (ESD) for gastrointestinal (GI) cancers.
Primary Outcome
* Ease of use of overall procedure as rated on a 5-point visual analog scale for very easy, easy, neutral, difficult and very difficult. * Time (in minutes) needed to resect the lesion completely, as measured from the first injection to final excision of the lesion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-03 |
What the finished NCT01415609 record still lists
NCT01415609 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01415609 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01415609 about?
NCT01415609 is a clinical study titled "Endoscopic Submucosal Dissection Registry". The purpose of this study is to monitor the success rates and completion rates for endoscopic submucosal dissection (ESD) for gastrointestinal (GI) cancers.
What is the current status of trial NCT01415609?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2010-08. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT01415609?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia